RLT Booklet.pdf

www.neuroendocrinecancer.org.uk

Radioligand Therapy cannot cure neuroendocrine cancer, but it can: Reduce the size and number of neuroendocrine tumours Slow down neuroendocrine tumour growth Reduce hormone overproduction, e.g., alleviate carcinoid syndrome or other hormone-related symptoms Provide relief from other neuroendocrine tumour-related symptoms, such as reducing tumour-related pain Improve quality of life Potentially extend life (improve overall survival).

How will I know whether this treatment is suitable for me?

Your specialist team will be able to determine whether this treatment could be used to treat your neuroendocrine cancer, and they should discuss this with you.

RLT is suitable for individuals with neuroendocrine tumours that have treatment- specific receptors.

Even if your specialist team believes you may be a good candidate for RLT, further tests and scans may be required before it can be prescribed.

If you are receiving dialysis or have any issues with urine or faecal incontinence, this should be discussed with your treatment team. These conditions won’t prevent you from having RLT, but special arrangements may need to be made to ensure the safety of both you and your care team during and after treatment. It is also essential to inform your specialist team about any medications, supplements, or other health conditions or concerns you may have.

Made with FlippingBook Annual report maker